Home
World Journal of Advanced Research and Reviews
International Journal with High Impact Factor for fast publication of Research and Review articles

Main navigation

  • Home
    • Journal Information
    • Editorial Board Members
    • Reviewer Panel
    • Abstracting and Indexing
    • Journal Policies
    • Our CrossMark Policy
    • Publication Ethics
    • Issue in Progress
    • Current Issue
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Join Editorial Board
    • Join Reviewer Panel
  • Contact us
  • Downloads

eISSN: 2581-9615 || CODEN: WJARAI || Impact Factor 8.2 ||  CrossRef DOI

Research and review articles are invited for publication in March 2026 (Volume 29, Issue 3) Submit manuscript

A comparative study on safety profile and efficacy of salmeterol and tiotropium in COPD Patients

Breadcrumb

  • Home
  • A comparative study on safety profile and efficacy of salmeterol and tiotropium in COPD Patients

Kenchugundu Jagadeesh *, Rayachooti Vandana, Bhyalla Akshay Varun, Dr. Gadwala Vinod and Bariki Rajasekhar

Department of Pharmacy Practice, St. Johns college of Pharmaceutical Sciences, Yemmiganur, Kurnool, Andhra Pradesh, India.
 
Research Article
World Journal of Advanced Research and Reviews, 2024, 22(02), 1306-1312
Article DOI: 10.30574/wjarr.2024.22.2.1505
DOI url: https://doi.org/10.30574/wjarr.2024.22.2.1505
 
Received on 07 April 2024; revised on 13 May 2024; accepted on 16 May 2024
 
Aim and Objectives: The aim of the study is assess the safety profile and efficacy of salmeterol and Tiotropium in patients with COPD. The objective is to compare to evaluate the safety profile and efficacy of salmeterol and Tiotropium in patients with COPD.
Methodology: This was a prospective observational study conducted at secondary care hospital in India. In our study, we have included a total of 50 patients who are divided in to two groups based on their treatment and follow-ups was done for 12 weeks.
Results: Patients were divided into 2 equal groups to receive salmeterol and Tiotropium (25 subjects each). The mean FEV1 level at baseline was 63.72±3.0210 for Tiotropium group and 64.96±1.645 for Salmeterol group and the mean FEV1 level after 12 weeks of treatment was 72.12±1.423 for Tiotropium group and 70.68±1.973 for Salmeterol group. Tiotropium treatment were associated with significant decrease in FEV1 level from baseline to 12 weeks. (P*<0.05).
Conclusion: In our study, by performing the study, we concluded that tiotropium used once daily, produced superior bronchodilation and reduced dyspnea in patients with COPD when compared with salmeterol. Patients treated with tiotropium also indicated more improvement in their symptoms than those who treated with salmeterol. Because of these advantages, tiotropium should be considered first-line treatment in patients with COPD. While performing the safety parameters for a drug, side effects of tiotropium are less when compared to salmeterol.
 
COPD; FEV1; Salmeterol; Tiotropium
 
https://wjarr.com/sites/default/files/fulltext_pdf/WJARR-2024-1505.pdf

Preview Article PDF

Kenchugundu Jagadeesh, Rayachooti Vandana, Bhyalla Akshay Varun, Dr. Gadwala Vinod and Bariki Rajasekhar. A comparative study on safety profile and efficacy of salmeterol and tiotropium in COPD Patients. World Journal of Advanced Research and Reviews, 2024, 22(2), 1306-1312. Article DOI: https://doi.org/10.30574/wjarr.2024.22.2.1505

Copyright © Author(s). All rights reserved. This article is published under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as appropriate credit is given to the original author(s) and source, a link to the license is provided, and any changes made are indicated.

All statements, opinions, and data contained in this publication are solely those of the individual author(s) and contributor(s). The journal, editors, reviewers, and publisher disclaim any responsibility or liability for the content, including accuracy, completeness, or any consequences arising from its use.

Get Certificates

Get Publication Certificate

Download LoA

Check Corssref DOI details

Issue details

Issue Cover Page

Editorial Board

Table of content

Copyright © 2026 World Journal of Advanced Research and Reviews - All rights reserved

Developed & Designed by VS Infosolution